Chronic kidney disease (CKD) is associated with the development of mineral bone disorder
(MBD), osteoporosis, and fragility fractures. Among CKD patients, adynamic bone disease or …

The aim of this clinical narrative review is to summarize and critically appraise the literature
on the differential diagnosis of hypocalcemia and to provide its correct management …

Patients with CKD have a 4–fivefold higher rate of fractures. The incidence of fractures
increases with deterioration of kidney function. The process of skeletal changes in CKD …

Recent advances in surgical, immunosuppressive and monitoring protocols have led to the
significant improvement of overall one-year kidney allograft outcomes. Nonetheless, there …

Background Increases in bone mineral density (BMD) following a single dose of denosumab
and increased incidence of denosumab-associated acute hypocalcemia (DAAH) have been …

Renal transplantation (RTx) allows us to obtain the resolution of the uremic status but is not
frequently able to solve all the metabolic complications present during end-stage renal …

This study conducted a meta-analysis to analyze the efficacy and safety of osteoporosis
medications in kidney transplant recipients and patients with chronic kidney disease (CKD) …

Introduction: Denosumab represents a realistic treatment option to increase bone mineral
density in kidney transplant recipients (KTRs). It is still unknown how and at what extent …

A correlation between impaired bone metabolism, chronic kidney disease, and
cardiovascular diseases (CVD) has been suggested. This study aimed to compare the …

Background Denosumab and alendronate had a positive impact on bone mineral density
(BMD) preservation after kidney transplantation. However, the cost-effectiveness of these …